EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review

Katharine Valéria Saraiva Hodel iD, Bianca Sampaio Dotto Fiuza, Rodrigo Souza Conceição iD, Augusto Cezar Magalhães Aleluia iD, Thassila Nogueira Pitanga, Larissa Moraes Dos Santos Fonseca iD, Camila Oliveira Valente, Cintia Silva Minafra-Rezende iD, Bruna Aparecida Souza Machado

Pharmaceuticals · 19.06.2024 · 17 (6) · 807

DOI: 10.3390/ph17060807 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 19.06.2024. Verfasst von Katharine Valéria Saraiva Hodel und 8 weiteren Autor:innen. Beteiligte Einrichtung: SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CIMATEC University Center, Salvador 41650-010, Bahia State, B…. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 410 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, CNPq Brazil—“Conselho Nacional de Desenvolvimento Científico e Tecnológico”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacovigilance plays a central role in safeguarding public health by continuously monitoring the safety of vaccines, being critical in a climate of vaccine hesitancy, where public trust is paramount. Pharmacovigilance strategies employed to gather information on adverse events following immunization (AEFIs) include pre-registration data, media reports, clinical trials, and societal reporting. Early detection of AEFIs during clinical trials is crucial for thorough safety analysis and preventing serious reactions once vaccines are deployed. This review highlights the importance of societal reporting, encompassing contributions from community members, healthcare workers, and pharmaceutical companies. Technological advancements such as quick response (QR) codes can facilitate prompt AEFI reporting. While vaccines are demonstrably safe, the possibility of adverse events necessitates continuous post-marketing surveillance. However, underreporting remains a challenge, underscoring the critical role of public engagement in pharmacovigilance. This narrative review comprehensively examines and synthesizes key aspects of virus vaccine pharmacovigilance, with special considerations for specific population groups. We explore applicable legislation, the spectrum of AEFIs associated with major vaccines, and the unique challenges and perspectives surrounding pharmacovigilance in this domain.

Schlagwörter

Stichwörter der Autor:innen

adverse eventsadverse events following immunizationpharmacovigilancevaccines

Autor:innen und Institutionen

  • SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CIMATEC University Center, Salvador 41650-010, Bahia State, Brazil.
  • Department of Medicine, College of Pharmacy, Federal University of Bahia, Salvador 40170-115, Bahia State, Brazil.
  • Department of Natural Sciences, Southwestern Bahia State University (UESB), Campus Vitória da Conquista, Vitória da Conquista 45031-300, Bahia State, Brazil.
  • Laboratory for Research in Genetics and Translational Hematology, Gonçalo Moniz Institute, FIOCRUZ-BA, Salvador 40296-710, Bahia State, Brazil.
  • Faculty of Veterinary and Animal Science, Federal University of Goiás, Goiânia 74690-900, Goiás State, Brazil.

ORCID-Profile: Katharine Valéria Saraiva Hodel, Rodrigo Souza Conceição, Augusto Cezar Magalhães Aleluia, Larissa Moraes Dos Santos Fonseca, Cintia Silva Minafra-Rezende

Förderung

  • National Council for Scientific and Technological Development
  • CNPq Brazil—“Conselho Nacional de Desenvolvimento Científico e Tecnológico”

Zitieren

APA

Hodel, K. V. S., Fiuza, B. S. D., Conceição, R. S., Aleluia, A. C. M., Pitanga, T. N., Fonseca, L. M. D. S., Valente, C. O., Minafra-Rezende, C. S., & Machado, B. A. S. (2024). Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review. Pharmaceuticals, 17(6), 807. https://doi.org/10.3390/ph17060807

Vancouver

Hodel KVS, Fiuza BSD, Conceição RS, Aleluia ACM, Pitanga TN, Fonseca LMDS, et al. Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review. Pharmaceuticals. 2024;17(6):807. doi:10.3390/ph17060807

BibTeX
@article{Hodel2024,
  author = {Hodel, Katharine Valéria Saraiva and Fiuza, Bianca Sampaio Dotto and Conceição, Rodrigo Souza and Aleluia, Augusto Cezar Magalhães and Pitanga, Thassila Nogueira and Fonseca, Larissa Moraes Dos Santos and Valente, Camila Oliveira and Minafra-Rezende, Cintia Silva and Machado, Bruna Aparecida Souza},
  title = {Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {6},
  pages = {807},
  doi = {10.3390/ph17060807}
}
Kostenlos starten →